In this study, we compared the effects of daily, high-dose vitamin D supplementation on the gene expression profiles of CD4+ T cells, CD14+ monocytes, and CD19+ B cells at baseline and again at 6 months among 18 MS patients enrolled in a clinical trial. The gene discussed is CD19; the disease is myeloid sarcoma.